Biliary sterol secretion is not required for macrophage reverse cholesterol transport.

Cell Metabolism
Ryan E TemelJ Mark Brown

Abstract

Recent evidence suggests that the intestine may play a direct facilitative role in reverse cholesterol transport (RCT), independent of hepatobiliary secretion. In order to understand the nonbiliary pathway for RCT, we created both genetic and surgical models of biliary cholesterol insufficiency. To genetically inhibit biliary cholesterol secretion, we generated mice in which Niemann-Pick C1-Like 1 (NPC1L1) was overexpressed in the liver. Compared to controls, NPC1L1(Liver-Tg) mice exhibit a >90% decrease in biliary cholesterol secretion, yet mass fecal sterol loss and macrophage RCT are normal. To surgically inhibit biliary emptying into the intestine, we have established an acute biliary diversion model. Strikingly, macrophage RCT persists in mice surgically lacking the ability to secrete bile into the intestine. Collectively, these studies demonstrate that mass fecal sterol loss and macrophage RCT can proceed in the absence of biliary sterol secretion, challenging the obligate role of bile in RCT.

References

Feb 1, 1968·The Journal of Clinical Investigation·J M Dietschy
May 1, 1967·The Journal of Clinical Investigation·W J SimmondsE Theodor
Jul 10, 2002·The Journal of Biological Chemistry·Torsten PlōschFolkert Kuipers
Nov 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Liqing YuHelen H Hobbs
Jun 1, 1959·Proceedings of the Society for Experimental Biology and Medicine·S H CHENG, M M STANLEY
Jun 25, 2005·Circulation Research·Gary F Lewis, Daniel J Rader
Jun 9, 2007·Current Opinion in Cardiology·Xun Wang, Daniel J Rader
Jun 16, 2007·The Journal of Clinical Investigation·Ryan E TemelLiqing Yu
Jul 28, 2007·The Journal of Clinical Investigation·Xun WangDaniel J Rader
May 31, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Astrid E van der VeldeAlbert K Groen
Dec 10, 2008·Journal of Lipid Research·Daniel J RaderGeorge H Rothblat
May 7, 2009·The Journal of Biological Chemistry·Jelske N van der VeenFolkert Kuipers

❮ Previous
Next ❯

Citations

Apr 16, 2011·Current Opinion in Lipidology·Camilla PramfalkPaolo Parini
Jan 21, 2012·Current Opinion in Lipidology·Ryan E Temel, J Mark Brown
Jul 20, 2012·Physiological Reviews·Nada A Abumrad, Nicholas O Davidson
Apr 14, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Kimberly T HungJonathan D Smith
Oct 2, 2012·Circulation Research·Sonika SaddarPhilip W Shaul
Apr 10, 2012·The Journal of Clinical Investigation·Yuan ZhangIra G Schulman
Mar 26, 2013·The Journal of Clinical Investigation·Catherine MartelGwendalyn J Randolph
Jul 18, 2012·Journal of Lipid Research·Carlos L J VrinsAlbert K Groen
May 17, 2014·Nature Reviews. Drug Discovery·Cynthia Hong, Peter Tontonoz
Aug 2, 2011·Expert Opinion on Therapeutic Targets·Ronald Pj Oude Elferink, Ulrich Beuers
Nov 20, 2012·Trends in Endocrinology and Metabolism : TEM·Barbara Bonamassa, Antonio Moschetta
Jun 23, 2012·Molecular and Cellular Endocrinology·Mariëtte Y M van der WulpAlbert K Groen
Jul 15, 2015·Atherosclerosis·Stephen D Lee, Peter Tontonoz
Feb 26, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Alberto Dávalos, Carlos Fernández-Hernando
May 7, 2015·Biomolecular Concepts·Marion Korach-André, Jan-Åke Gustafsson
May 2, 2015·Trends in Pharmacological Sciences·Ryan E Temel, J Mark Brown
Jul 6, 2014·Biochimica Et Biophysica Acta·Harumi Uto-KondoKatsunori Ikewaki
Feb 25, 2014·Molecular Aspects of Medicine·Albert K GroenFolkert Kuipers
Apr 24, 2013·Progress in Lipid Research·Miriam Lee-RueckertJoan Carles Escola-Gil
Jul 26, 2014·Metabolism: Clinical and Experimental·Jessica B AltemusEphraim Sehayek
Nov 8, 2014·Journal of Lipid Research·Jin WangHelen H Hobbs
Apr 9, 2013·Journal of Lipid Research·Kanwardeep S BuraJ Mark Brown
Jan 30, 2014·Journal of Lipid Research·Yan XieNicholas O Davidson

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved